Harvard Bioscience Stock Price and Value Analysis

Should you buy Harvard Bioscience stock? (NasdaqGM:HBIO). Let's see how it does in our automated value investing analysis system.

AdvantagesDisadvantagesNeutral
  • This company is solid.
  • This company is making money at a modest rate.
  • This stock looks overpriced.
  • This company has wild ups and downs.
  • This company pays no dividend.

Inside the HBIO Numbers

HBIO Price
(Harvard Bioscience stock price per share)
$7.07
[?] HBIO Fair Price
(based on intrinsic value)
$2.81
[?] HBIO Safety Price (based on a variable margin of safety) $1.83
[?] PE Ratio versus Sector 3121% higher than other Healthcare stocks
[?] PE Ratio versus Industry 2608% higher than other Medical Instruments & Supplies stocks
[?] Cash Yield 1.45%
[?] Free Cash Flow Jitter 100%

This stock has short interest! This means that people have shorted it.

Why does that matter? They've made a bet that price will decrease from where they bought it. Maybe there are financial problems, or maybe there's a value play.

As of the latest analysis, there are 798,201 shares shorted. With 35,776,443 shares available for purchase and an average trading volume over the past 10 trading days of 137,737, it would take at least 5.795 days for all of the short holders to cover their shorts.

Is Harvard Bioscience Stock on Sale?

We believe that Harvard Bioscience may be worth examining further. It's making money, which is a very positive sign. Is it on sale?

Harvard Bioscience looks overpriced right now. If you're looking for a bargain in the stock market, you should probably look elsewhere for a great deal. This might still be a great stock to own—but it's not on sale right now.

Should You Buy HBIO Stock?

Does Harvard Bioscience have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.